These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6318127)

  • 1. Electrophysiological effects of diltiazem, nifedipine and Ni2+ on the subepicardial muscle cells of canine heart under the condition of combined hypoxia, hyperkalemia and acidosis.
    Kimura S; Nakaya H; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):228-32. PubMed ID: 6318127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of actions involved in improved effects of calcium channel blockers on ischemic myocardial conduction delay].
    Kimura S
    Hokkaido Igaku Zasshi; 1983 Sep; 58(5):490-501. PubMed ID: 6662484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of verapamil and lidocaine on changes in action potential characteristics and conduction time induced by combined hypoxia, hyperkalemia, and acidosis in canine ventricular myocardium.
    Kimura S; Nakaya H; Kanno M
    J Cardiovasc Pharmacol; 1982; 4(4):658-67. PubMed ID: 6181342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.
    Narimatsu A; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):169-77. PubMed ID: 1012337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the calcium antagonist diltiazem on action potentials, slow response and force of contraction in different cardiac tissues.
    Hirth C; Borchard U; Hafner D
    J Mol Cell Cardiol; 1983 Dec; 15(12):799-809. PubMed ID: 6663628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
    Lathrop DA; Valle-Aguilera JR; Millard RW; Gaum WE; Hannon DW; Francis PD; Nakaya H; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):613-20. PubMed ID: 7058769
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.
    Motomura S; Hashimoto K
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):445-57. PubMed ID: 8527355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
    Nakaya H; Hattori Y; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of clentiazem, a new Ca2+ antagonist, on rabbit hearts.
    Miyazaki K; Adaniya H; Sawanobori T; Hiraoka M
    J Cardiovasc Pharmacol; 1996 May; 27(5):615-21. PubMed ID: 8859929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
    Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Ca2+ channel antagonists and ryanodine on H1-receptor mediated electromechanical response to histamine in guinea-pig left atria.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):323-30. PubMed ID: 3393235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs.
    Walsh RA; Badke FR; O'Rourke RA
    Am Heart J; 1981 Sep; 102(3 Pt 1):341-50. PubMed ID: 6267919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of lidocaine and quinidine on impulse propagation across the canine Purkinje-muscle junction during combined hyperkalemia, hypoxia, and acidosis.
    Evans JJ; Gilmour RF; Zipes DP
    Circ Res; 1984 Aug; 55(2):185-96. PubMed ID: 6744528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.